Stockscreener 앱 받기
0.629
4.82%
0.0289
시간 외 거래:
.60
-0.029
-4.61%
Icecure Medical Ltd 주식(ICCM)의 최신 뉴스
ICCM SEC FilingsIcecure Medical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript - Insider Monkey
IceCure reports net loss of USD 15,057,000 in 2025 - Medical Buyer
Icecure Medical Rides FDA, ASBRS Wins to Growth - TipRanks
IceCure Medical Discloses Resignation of Director Li Haixiang - TipRanks
IceCure Medical (ICCM) director Li Haixiang steps down from board - Stock Titan
IceCure Medical (ICCM) Q4 2025 Earnings Transcript - AOL.com
IceCure Medical 2025 Financial Results Review | ProSense System UpdatesNews and Statistics - IndexBox
IceCure Medical (ICCM) Fourth Quarter 2025 Earnings Call Transcript - Bitget
IceCure Medical Ltd Q4 2025 Earnings Call Summary - Yahoo Finance
ICCM: Record revenue and regulatory milestones drive rapid adoption and expansion for ProSense - TradingView
ICCM: Record revenue and regulatory milestones fuel rapid adoption and growth outlook for ProSense - TradingView
IceCure Medical Ltd Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ICCM Reports Record FY25 Revenue Growth Following Key FDA Cleara - GuruFocus
IceCure Medical Posts Record 2025 Sales as ProSense Cryoablation Adoption Accelerates Post-FDA Clearance - TipRanks
Icecure Medical Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
IceCure Medical (NASDAQ: ICCM) 20-F details going concern risk and FDA breast cancer OK - Stock Titan
IceCure Reports 2025 Full Year Financial & Operational Results - PR Newswire
Hedge Fund Bets: Is IceCure Medical Ltd forming a breakout pattern2026 Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
IceCure (ICCM) updates auditor consent in Form F-3/A shelf amendment - Stock Titan
What To Expect From Icecure Medical Ltd (ICCM) Q4 2025 Earnings - GuruFocus
IceCure Medical : Company Presentation - marketscreener.com
New Highs: Is IceCure Medical Ltd subject to activist investor interest2026 Trade Ideas & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Icecure Medical Ltd expected to post a loss of 4 cents a shareEarnings Preview - TradingView
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense Cryoablation in the Local Treatment of Low-Risk Breast Cancer - Finviz
FDA Greenlights IceCure’s ProSense® Study for Breast Cancer - Zenopa
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for Pr - GuruFocus
IceCure Wins FDA Nod for U.S. Post-Marketing ChoICE Study of ProSense Cryoablation in Low-Risk Breast Cancer - TipRanks
FDA clears IceCure (Nasdaq: ICCM) ProSense post-market ChoICE study in breast cancer - Stock Titan
IceCure Medical (ICCM) Receives FDA Approval for Post-Market Stu - GuruFocus
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer - PR Newswire
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 - The Malaysian Reserve
Movement Recap: Is IceCure Medical Ltd showing insider buyingRecession Risk & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Tumor-freezing firm IceCure to detail 2025 results on Mar. 17 - Stock Titan
American Society of Breast Surgeons (ASBrS) Resource Guide Updat - GuruFocus
IceCure Gains Key ASBrS Backing for ProSense Cryoablation in Low-Risk Breast Cancer - TipRanks
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer - PR Newswire
Meme Stocks: Can IceCure Medical Ltd outperform under higher oil pricesTrade Performance Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Bank Watch: Is IceCure Medical Ltd a strong candidate for buy and holdJuly 2025 WrapUp & Smart Swing Trading Techniques - baoquankhu1.vn
Sell Signal: Is IceCure Medical Ltd a stock for growth or value investors2025 Market WrapUp & AI Powered Market Trend Analysis - baoquankhu1.vn
Does IceCure Medical Ltd outperform in volatile markets2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
IceCure Medical Highlights New PLOS One Data Showing ProSense Cryoablation Effective for Breast Fibroadenomas - TipRanks
Independent ProSense study on breast tumors for IceCure (ICCM) - Stock Titan
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas - Barchart.com
ICCM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ICCM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ICCM Should I Buy - Intellectia AI
ICCM Completes Key 5-Year Follow-Up in Kidney Cancer Clinical Tr - GuruFocus
IceCure Medical Completes Five-Year Follow Up in ICESECRET Kidney Cancer Cryoablation Study - TipRanks
S P Trends: Is IceCure Medical Ltd subject to activist investor interest2025 Volatility Report & Risk Managed Trade Strategies - baoquankhu1.vn
IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026 - PR Newswire
A freezing treatment for kidney tumors just finished 5 years of testing - Stock Titan
Is IceCure Medical Ltd stock a good dividend stock2025 Technical Overview & Low Risk Profit Maximizing Plans - mfd.ru
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - marketscreener.com
Is IceCure Medical Ltd stock overvalued by current metricsWeekly Investment Recap & Technical Pattern Based Buy Signals - mfd.ru
IceCure Medical Ltd. Announces Thomas Hospital of Infirmary Health Installs ProSense®?, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - marketscreener.com
IceCure Announces Thomas Hospital of Infirmary Health Installs P - GuruFocus
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense®, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - PR Newswire
Aug Weekly: Does IceCure Medical Ltd outperform in volatile marketsEarnings Risk Report & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Stock Report: Is IceCure Medical Ltd a strong candidate for buy and hold2025 Retail Activity & Free Community Consensus Stock Picks - baoquankhu1.vn
Is IceCure Medical Ltd subject to activist investor interestWeekly Investment Summary & Stepwise Trade Signal Guides - mfd.ru
Stock Market Recap: How does Universal Corporation compare to its peersInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
What’s the MACD signal for IceCure Medical LtdOptions Play & AI Forecasted Entry/Exit Points - mfd.ru
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense - Finviz
0.85%
1.86%
자본화:
|
볼륨(24시간):